First-degree relatives who later develop RA exhibit widespread Fab glycosylation even before disease onset, indicating that ACPA-IgG Fab glycosylation levels may serve as a predictive biomarker for the development of ACPA-positive RA [37]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.